Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?

Huibers, Minke;Abla, Oussama;Andrés, Mara;Balagué, Olga;Attarbaschi, Andishe;et.al.
(2024) Blood Advances — Vol. 8, n° 6, p. 1509-1514 (2024)

Files

LargeB-celllymphoma-IRF4inchildrenandyoungpeople.pdf
  • Open Access
  • Adobe PDF
  • 631.96 KB

Details

Authors
  • Huibers, Minke
    Author
  • Abla, Oussama
    Author
  • Andrés, Mara
    Author
  • Balagué, Olga
    Author
  • Attarbaschi, Andishe
    Author
Show more
Affiliations

Citations

Huibers, M., Abla, O., Andrés, M., Balagué, O., Beishuizen, A., Carraro, E., Chiang, A., Csóka, M., David, B.-A., de Ville de Goyet, M., Gilad, G., Hori, D., Kotecha, R. S., Kabickova, E., Klapper, W., Miakova, N., Minard-Colin, V., Nakazawa, A., Pillon, M., et al. (2024). Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm? Blood Advances, 8(6), 1509-1514. https://doi.org/10.1182/bloodadvances.2023012109 (Original work published 2024)